We Doc Pharmaceuticals Private Limited

We Doc Pharmaceuticals Private Limited - trading in Delhi, India. FY 2026 financials & compliance.
CIN U24233DL1998PTC096832 Incorporated 27 October 1998 ROC Delhi HQ Delhi, India
Active Private Limited Company trading
Revenue · FY 2025
₹16.85 Lakh
▼ 38% YoY
Net loss · FY 2025
₹59,247
Net margin -3.5%
EBITDA · FY 2025
-₹57,725
EBITDA margin -3.4%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹9.86 Lakh
Issued & subscribed
Company age
28 yrs
Est. 1998
Directors on board
2
As per MCA filings
Active GSTINs
2
GST registered

About We Doc Pharmaceuticals Private Limited

Data last updated:

We Doc Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 27 October 1998 and has been in existence for over 28 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24233DL1998PTC096832. Its GSTIN is 07AAACW2511K1ZH (Delhi). The company holds 2 GST registrations, all of them active.

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹9.86 Lakh. It is led by directors Nagendra Kumar Sinha and Manoj Kumar.

Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C – 80 Ganesh Nagar 2nd Floor Pandav Nagar Complex, Delhi, India – 110092.

As per the financials filed for FY 2025, the company reported a revenue of ₹16.85 Lakh, a decline of 38% compared to the previous year. For the same year it recorded a net loss of ₹59,247 (net margin -3.5%) and EBITDA of -₹57,725 (EBITDA margin -3.4%). Revenue has declined at a compounded annual rate (CAGR) of 16% over three years and 2% over five years.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24233DL1998PTC096832
Registration Number 096832
Incorporation Date 27 October 1998
ROC Delhi
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

Contact details

We Doc Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    C – 80 Ganesh Nagar 2nd Floor Pandav Nagar Complex, Delhi, India – 110092
  • Industry
    Trading, Wholesale, Other Wholesale

To see the full contact details of We Doc Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
We Doc Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of We Doc Pharmaceuticals is trade. In detail, this covers retail trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG2Retail Trading

To see the full business activity and turnover split of We Doc Pharmaceuticals Private Limited, buy the company report.

Financials of We Doc Pharmaceuticals Private Limited

FY 2025 filings available

We Doc Pharmaceuticals Private Limited reported revenue of ₹16.85 Lakh (down 38% YoY) for FY 2025.

Revenue · FY 2025
₹16.85 Lakh ▼ 38%
Net loss · FY 2025
₹59,247 margin -3.5%
EBITDA · FY 2025
-₹57,725 margin -3.4%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 38%
3 years · compounded
▼ 16%
5 years · compounded
▼ 2%
EBITDA CAGR growth
3 years · compounded
▼ 97%
5 years · compounded
▼ 45%

Revenue has declined at a compounded annual rate (CAGR) of 2% over five years, including a 38% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹57,725
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹59,247
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin-3.4%
Net Profit Margin-3.5%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of We Doc Pharmaceuticals Private Limited, buy the company report.

Board of directors of We Doc Pharmaceuticals Private Limited

We Doc Pharmaceuticals has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Nagendra Kumar SinhaDirector27 Oct 199828 Years 0 MonthsCurrent
Manoj KumarDirector27 Oct 199828 Years 0 MonthsCurrent

Peer comparison

We Doc Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (retail trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Anoush Pharmaceuticals India Private Limited₹16.94 Lakh (FY 2023)21.0%Hoshiarpur, Punjab, India
We Doc Pharmaceuticals Private Limitedthis company₹16.85 Lakh (FY 2025)-₹59,247-3.5%-38.0%Delhi, India
Shirama Pharmaceuticals Private Limited₹16.84 Lakh (FY 2024)85.0%Varanasi, Uttar Pradesh, India
Turio Pharmaceuticals Private Limited₹16.81 Lakh (FY 2024)1265.0%Hyderabad, Telangana, India

To see the full peer comparison of We Doc Pharmaceuticals Private Limited, buy the company report.

Auditor

We Doc Pharmaceuticals Private Limited is audited by UKS & ASSOCIATES for the financial year 2017.

Auditor firmFinancial yearFirm registration number
UKS & ASSOCIATESFY 2017013015N

Shareholding

The shareholding of We Doc Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of We Doc Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for We Doc Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

We Doc Pharmaceuticals has 2 GST registrations: 2 active.

Total GSTINs
2
Active
2
GSTINStateStatusRegistered on
07AAACW2511K1ZHDelhiActive01 Jul 2017
24AAACW2511K1ZLGujaratActive01 Jul 2017

To see the full GST registrations and return filing status of We Doc Pharmaceuticals Private Limited, buy the company report.

Recent activity

We Doc Pharmaceuticals Private Limited has 2 board changes on record since 1998: 2 appointments. The latest: Manoj Kumar was appointed as Director on 27 Oct 1998.

AGM
We Doc Pharmaceuticals Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Filing
We Doc Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Appointed
Manoj Kumar was appointed as Director.
Appointed
Nagendra Kumar Sinha was appointed as Director.
Incorporation
27 Oct 1998
We Doc Pharmaceuticals Private Limited was registered on 27 Oct 1998 with Roc Delhi & aged 28 years 26 days as per MCA records.

Frequently asked questions

We Doc Pharmaceuticals is an active private limited company based in Delhi, India. The company works in wholesale, within the trading industry. It was incorporated on 27 October 1998 (28+ years old) and is registered under CIN U24233DL1998PTC096832.

We Doc Pharmaceuticals has 2 current directors:

The latest financial statements of We Doc Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of We Doc Pharmaceuticals is 07AAACW2511K1ZH, registered in Delhi. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 24AAACW2511K1ZL (Gujarat).

The CIN (Corporate Identification Number) of We Doc Pharmaceuticals is U24233DL1998PTC096832. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

We Doc Pharmaceuticals was incorporated on 27 October 1998, making it 28+ years old. It is registered with the Registrar of Companies, Delhi.

The peers of We Doc Pharmaceuticals by revenue are Anoush Pharmaceuticals India Private Limited, Shirama Pharmaceuticals Private Limited, Turio Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (retail trading).

Manoj Kumar was appointed as Director on 27 Oct 1998. Nagendra Kumar Sinha was appointed as Director on 27 Oct 1998.

The registered office of We Doc Pharmaceuticals is at C – 80 Ganesh Nagar 2nd Floor Pandav Nagar Complex, Delhi, India – 110092.

We Doc Pharmaceuticals operates in the trading industry, in the wholesale segment.

The compliance status of We Doc Pharmaceuticals is compliant as of 21 July 2026. The company is actively filing with the Registrar of Companies.